Daito Pharmaceutical Co.,Ltd.

TSE:4577.T

2227 (JPY) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

2023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22010 Q42010 Q32010 Q22010 Q1
Operating Activities:
Net Income 9567878696839408988169466901,2019521,8255471,2761,1021,3217031,2391,082920963877894779741713914673613620752671655644589678728408654456562338508403661215520263.742517.039600.102297.17
Depreciation & Amortization 008678301,019981951919000000000000000000000000000000000000000629.292577.653452.791433.275
Deferred Income Tax 000000000000000000000000000000000000000000000000000
Stock Based Compensation 000000000000000000000000000000000000000000000000000
Change In Working Capital 00000000000000000000000000000000000000000000000-43.466-284.831-331.335-133.817
Accounts Receivables 000000000000000000000000000000000000000000000000000
Change In Inventory 00000000000000000000000000000000000000000000000256.568-351.88738.892-519.535
Change In Accounts Payables 000000000000000000000000000000000000000000000000000
Other Working Capital 00000000000000000000000000000000000000000000000-300.03467.056-370.227385.718
Other Non Cash Items -956-787-869-683-940-898-816-946-690-1,201-952-1,825-547-1,276-1,102-1,321-703-1,239-1,082-920-963-877-894-779-741-713-914-673-613-620-752-671-655-644-589-678-728-408-654-456-562-338-508-403-661-215-520568.413-298.66167.605-485.889
Operating Cash Flow 001,7341,6602,0381,9621,9021,8380000000000000000000000000000000000000001,417.981511.2789.163110.739
Investing Activities:
Investments In Property Plant And Equipment 00000000000000000000000000000000000000000000000-693.726-913.304-653.401-806.311
Acquisitions Net 0000000000000000000000000000000000000000000000071.044-14.06500
Purchases Of Investments 00000000000000000000000000000000000000000000000-29.92-13.182-38.426-0.335
Sales Maturities Of Investments 0000000000000000000000000000000000000000000000010.33800
Other Investing Activites 00000000000000000000000000000000000000000000000-102.648-29.563-41.831-13.874
Investing Cash Flow 00000000000000000000000000000000000000000000000-895.683-941.876-677.104-820.52
Financing Activities:
Debt Repayment 00000000000000000000000000000000000000000000000-714.011-562.169-979.786-381.437
Common Stock Issued 00000000000000000000000000000000000000000000000142.3621,146.4920603.252
Common Stock Repurchased 00000000000000000000000000000000000000000000000-0.068-0.0580-0.115
Dividends Paid 00000000000000000000000000000000000000000000000-0.28-0.29-12.123-166.084
Other Financing Activities 00000000000000000000000000000000000000000000000142.3631,146.491575.195603.251
Financing Cash Flow 00000000000000000000000000000000000000000000000-571.996583.974-416.71455.615
Other Information:
Effect Of Forex Changes On Cash 000000000000000000000000000000000000000000000001.008-1.3621.786-1.949
Net Change In Cash 00583395-35-2,2405001,001000000000000000000000000000000000000000-48.691151.937-302.869-656.116
Cash At End Of Period 004,5854,0023,6073,6425,8825,3820000000000000000000000000000000000000001,751.2031,799.8941,647.9571,950.826